Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 64 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Cash Flows from Operating Activities              
Net loss $ (434,104) $ (530,307) $ (935,388) $ (298,323) $ (1,254,043) $ (1,519,561) $ 6,748,236
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation         126 567  
Amortization - patents         60,172 60,172  
Amortization - debt discount         296,738 45,134  
Options issued for services         73,773 724,631  
Common stock issued for services         39,807  
Change in:              
Prepaid expenses         (89,579) 11,229  
Deposits         2,315  
Accounts payable and accrued liabilities         (124,160) 409,381  
Net cash used in operating activities         (1,034,659) (228,640)  
Cash Flows from Financing Activities              
Payments on insurance premium financing         (46,986) (36,680)  
Proceeds from debt and warrants issued         1,047,151 270,000  
Net cash provided by financing activities         1,000,165 233,320  
Net change in cash         (34,494) 4,680  
Cash, beginning of period   58,149   $ 4,001 58,149 4,001  
Cash, end of period 23,655   $ 8,681   23,655 8,681 $ 23,655
Supplemental Disclosure of Cash flow Information              
Cash paid during the period for interest         50,271 2,921  
Non-Cash Financing Activities              
Notes payable converted to common stock   $ 300,000     300,000  
Stock options exchanged for common stock       360  
Options issued for accounts payable         115,869  
Common stock issued to satisfy liabilities         19,054  
Recognition of beneficial conversion feature         $ 737,437